The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

In a letter, the undersigned asked Congress to halt cuts to Medicare reimbursement and enact a permanent system to adjust rates to inflation. 

The Biden Administration has invoked parts of the Defense Production Act to address shortages that stem from Hurricane Helene damaging a Baxter production facility in North Carolina. 

The news comes just days after CMS confirmed these technologies would start receiving expanded Medicare coverage in November. HeartFlow and other AI vendors have already shared their excitement over the decision. 

The software is a collaboration between Bracco Diagnostics, a subsidiary of Bracco Imaging, and Subtle Medical, Inc.

Imaging plays an essential role in addressing hepatic steatosis. Yet, radiologists have had almost zero involvement in shaping medical knowledge about the disease. 

ACR, the Society of Interventional Radiology and others recently submitted a letter to 5 of the 7 contractors, expressing concern about trigger-point injections. 

The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden.